Masciotra Silvina, Owen Sherry M, Rudolph Donna, Yang Chunfu, Wang Bin, Saksena Nitin, Spira Thomas, Dhawan Subhash, Lal Renu B
HIV Immunology and Diagnostics Branch, Division of AIDS, STD, TB Laboratory Research, National Center for Infectious Diseases, Centers for Diseases Control and Prevention, Atlanta, Georgia 30333, USA.
AIDS. 2002 Sep 27;16(14):1887-98. doi: 10.1097/00002030-200209270-00005.
Specific mutations in VPR and V2 potentially restrict HIV-1 replication in macrophages. Such restriction could potentially limit HIV replication in long-term non-progressors (LTNP), thus accounting for low viral load and delayed progression to AIDS.
To examine whether a specific VPR phenotype (truncated versus non-truncated) correlates with disease progression and whether elongated V2 restricts viral replication in macrophages or alters viral tropism.
Sequence analysis was carried for VPR and V1-V3 env from four rapid progressors (RPs), six late progressors (LPs), and three LTNPs in cohort of HIV-1-infected homosexual men. The replication kinetics of sequential isolates was examined in primary CD4 cells and macrophages and coreceptor usage was determined by GHOST infection assays.
No differences were found in the VPR protein from RP and LTNP isolates. Analysis of the V2 region revealed that all RPs maintained similar V2 lengths (40 aa), whereas LPs and LTNPs acquired additional amino acids (2-13 aa) in the V2 region. Coreceptor specificity revealed that RP switch from CCR5 to multiple coreceptor usage, whereas LTNPs maintained R5 viruses. Sequential isolates from each group revealed comparable replication efficiencies in both T-cells and macrophages, regardless of the V2 length or coreceptor utilization. In addition, cross-section analysis of six LTNPs from Australia revealed extended V2 with consistent usage of CCR5 coreceptor.
The present results suggest that acquisition of a V2 extension over time in HIV-1-infected LPs/LTNPs appears to correlate with maintenance of CCR5 usage among LTNPs. These findings may be important for a better understanding of the host interactions and disease progression.
VPR和V2中的特定突变可能会限制HIV-1在巨噬细胞中的复制。这种限制可能会限制HIV在长期不进展者(LTNP)中的复制,从而导致病毒载量低和艾滋病进展延迟。
研究特定的VPR表型(截短型与非截短型)是否与疾病进展相关,以及延长的V2是否会限制病毒在巨噬细胞中的复制或改变病毒嗜性。
对一组感染HIV-1的同性恋男性中的4名快速进展者(RP)、6名晚期进展者(LP)和3名长期不进展者的VPR和V1-V3 env进行序列分析。在原代CD4细胞和巨噬细胞中检测连续分离株的复制动力学,并通过GHOST感染试验确定共受体使用情况。
RP和LTNP分离株的VPR蛋白没有差异。对V2区域的分析显示,所有RP的V2长度相似(40个氨基酸),而LP和LTNP在V2区域获得了额外的氨基酸(2-13个氨基酸)。共受体特异性显示,RP从CCR5转换为多种共受体使用,而LTNP维持R5病毒。每组的连续分离株在T细胞和巨噬细胞中的复制效率相当,无论V2长度或共受体利用情况如何。此外,对来自澳大利亚的6名LTNP的横断面分析显示V2延长,且CCR5共受体使用一致。
目前的结果表明,在HIV-1感染的LP/LTNP中,随着时间的推移获得V2延长似乎与LTNP中CCR5使用的维持相关。这些发现可能有助于更好地理解宿主相互作用和疾病进展。